Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in Hemoglobin Retrieve available abstracts of 172 articles: HTML format

Single Articles

November 2023
1. SILVA BORBOREMA T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R, et al
   Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
   Hemoglobin. 2023;47:85-96.
   PubMed     Abstract available
   
   
   
2. SAEIDNIA M, Fazeli P, Farzi A, Atefy Nezhad M, et al
   An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
   Hemoglobin. 2023;47:56-70.
   PubMed     Abstract available
   
   
   
3. QIU Y, Wei S, Hou W, Lai K, et al
   Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare beta-Globin Mutations.
   Hemoglobin. 2023;47:52-55.
   PubMed     Abstract available
   
   
   
4. ARAUJO ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, et al
   Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
   Hemoglobin. 2023;47:71-79.
   PubMed     Abstract available
   
   
   
5. TANG HS, Xiong Y, Li DZ
   Fetal Hemoglobin H Hydrops Fetalis: Another Three Case Reports.
   Hemoglobin. 2023;47:102-104.
   PubMed     Abstract available
   
   
   
6. LIU D, Nong C, Lai F, Tang Y, et al
   Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia.
   Hemoglobin. 2023;47:80-84.
   PubMed     Abstract available
   
   
   
7. WU BD, Zhou XY, Xie MJ, Jin CC, et al
   Identification of a Novel 7-bp Deletion in the alpha-Globin Gene Cluster in One Chinese Family.
   Hemoglobin. 2023;47:49-51.
   PubMed     Abstract available
   
   
   
8. LONG J, Gong F, Sun L, Yu C, et al
   A novel alpha Globin Gene Cluster Duplication, alphaalphaalphaalpha(380) Heterozygous beta(0)-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype.
   Hemoglobin. 2023;47:25-30.
   PubMed     Abstract available
   
   
   
9. DEMIDOVA E, Salomashkina V, Selivanova D, Litvin E, et al
   Hb Ryazan: An Elongated C-Terminal beta-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25.
   Hemoglobin. 2023;47:97-101.
   PubMed     Abstract available
   
   
   
10. EGHBALI A, Ghaffari K, Shaykh Baygloo R, Eghbali A, et al
    Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
    Hemoglobin. 2023;47:42-48.
    PubMed     Abstract available
    
    
    
11. SEYDEL GS, Ayan D, Balci T, Bayraktar M, et al
    Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.
    Hemoglobin. 2023;47:36-41.
    PubMed     Abstract available
    
    
    July 2023
12. ABU-ISMAIL L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, et al
    COVID-19 and Anemia: What Do We Know So Far?
    Hemoglobin. 2023 Jul 31:1-8. doi: 10.1080/03630269.2023.2236546.
    PubMed     Abstract available
    
    
    May 2023
13. LIU L, Fu Q, Zhang D, Chen D, et al
    Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
    Hemoglobin. 2023 May 10:1-5. doi: 10.1080/03630269.2023.2206575.
    PubMed     Abstract available
    
    
    
14. AL-ZEBARI S, Al-Allawi NA, Nerweyi F
    Beta Globin Gene Cluster Haplotypes in Beta Thalassemia in the Kurdistan Region of Iraq.
    Hemoglobin. 2023;47:111-117.
    PubMed     Abstract available
    
    
    
15. SHAMOON R, Yassin A, Charkaneh A
    Detection of a Rare Mutation in the Initiation Codon of the beta-Globin Gene (HBB:C.2T > C; P.Met1Thr).
    Hemoglobin. 2023;47:118-121.
    PubMed     Abstract available
    
    
    
16. CHEN YP, Wu P, Wang H, Wu JF, et al
    A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C beta 68(E12) Leu-Pro]: A First Report in the Chinese Population.
    Hemoglobin. 2023;47:130-134.
    PubMed     Abstract available
    
    
    
17. KUMAR R, Ahmad SA, Ozdemir M, Sadayappan S, et al
    Mutation Spectrum of beta-Thalassemia in Some Ethnic Groups of North Maharashtra, India.
    Hemoglobin. 2023;47:105-110.
    PubMed     Abstract available
    
    
    January 2023
18. PUROHIT P, Mohanty PK, Panigrahi J, Das K, et al
    Effect of alpha(+) Thalassemia on the Severity of Plasmodium falciparum Malaria in Different Sickle Cell Genotypes in Indian Adults: A Hospital-Based Study.
    Hemoglobin. 2023;47:11-18.
    PubMed     Abstract available
    
    
    
19. KABIR T, Anwar S, Mourosi JT, Akter S, et al
    alpha- and beta-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh.
    Hemoglobin. 2023;47:3-10.
    PubMed     Abstract available
    
    
    
20. PAN L, Tian P, Chen S, Zhang R, et al
    Novel Promoter Mutation (HBB:C.-139_-138del) Associated with beta-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2023;47:21-24.
    PubMed     Abstract available
    
    
    November 2022
21. WEN YJ, Yu QX, Jiang F, Li DZ, et al
    Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
    Hemoglobin. 2022;46:347-350.
    PubMed     Abstract available
    
    
    
22. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
    Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
    Hemoglobin. 2022;46:297-302.
    PubMed     Abstract available
    
    
    
23. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
    Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
    Hemoglobin. 2022;46:308-311.
    PubMed     Abstract available
    
    
    
24. WU SM, Huang SR, Li C, Chen GL, et al
    Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
    Hemoglobin. 2022;46:341-343.
    PubMed     Abstract available
    
    
    
25. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
    Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
    Hemoglobin. 2022;46:317-324.
    PubMed     Abstract available
    
    
    
26. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
    Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
    Hemoglobin. 2022;46:303-307.
    PubMed     Abstract available
    
    
    
27. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
    A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
    Hemoglobin. 2022;46:338-340.
    PubMed     Abstract available
    
    
    
28. LONG J, Gong F, Sun L, Lai G, et al
    Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
    Hemoglobin. 2022;46:325-329.
    PubMed     Abstract available
    
    
    September 2022
29. YIN ZZ, Yao J, Wei FX, Chen CY, et al
    Targeted Next-Generation Sequencing Reveals a Large Novel beta-Thalassemia Deletion that Removes the Entire HBB Gene.
    Hemoglobin. 2022;46:290-295.
    PubMed     Abstract available
    
    
    
30. VACHHANI NA, Vekariya DJ, Colah RB, Kashiyani HN, et al
    Spectrum of beta-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.
    Hemoglobin. 2022;46:285-289.
    PubMed     Abstract available
    
    
    
31. WANG K, Yi T, Wu WT, Lu J, et al
    Investigation of the Distribution of Thalassemia in Children in Jiangxi Province, the People's Republic of China.
    Hemoglobin. 2022;46:272-276.
    PubMed     Abstract available
    
    
    August 2022
32. AMARASINGHA AADS, Silva HJRL, Perera PS, Premawardhena AP, et al
    Anemia in Sri Lanka: A Literature Review.
    Hemoglobin. 2022 Aug 24:1-11. doi: 10.1080/03630269.2022.2096460.
    PubMed     Abstract available
    
    
    July 2022
33. BAO XQ, Wang JC, Qin DQ, Yao CZ, et al
    A Novel 5 kb Deletion in the beta-Globin Gene Cluster Identified in a Chinese Patient.
    Hemoglobin. 2022;46:245-248.
    PubMed     Abstract available
    
    
    
34. WARANG PP, Shinde NS, Umare VD, Deshmukh PV, et al
    Role of Oxidative Stress and the Protective Effect of Fermented Papaya Preparation in Sickle Cell Disease.
    Hemoglobin. 2022;46:260-264.
    PubMed     Abstract available
    
    
    
35. FARMAKIS D, Angastiniotis M, El Ghoul MM, Cannon L, et al
    Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation.
    Hemoglobin. 2022;46:225-232.
    PubMed     Abstract available
    
    
    
36. LAM TT, Nguyen DT, Le QT, Nguyen DA, et al
    Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve alpha- and beta-Thalassemia Carrier Screening in Pregnant Women in Vietnam.
    Hemoglobin. 2022;46:233-239.
    PubMed     Abstract available
    
    
    
37. LOCKE M, Reddy PS, Badawy SM
    Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review.
    Hemoglobin. 2022;46:201-213.
    PubMed     Abstract available
    
    
    
38. LIN XM, Jiang F, Li J, Li DZ, et al
    Dominantly Inherited beta-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the beta-Globin Gene: Hb Xiangyang (HBB: c.393delT).
    Hemoglobin. 2022;46:253-255.
    PubMed     Abstract available
    
    
    
39. SEN A, Sen A, Dolai TK
    Diagnostic Dilemma of Hemoglobinopathies Using High Performance Liquid Chromatography Alone: A Case Report from a Resource-Constrained Setting.
    Hemoglobin. 2022;46:256-259.
    PubMed     Abstract available
    
    
    
40. LIAO J, Li Q, Ling LQ, Liu CN, et al
    A Triple-Heterozygous beta-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel beta(0) Mutation [an IVS-II-654 (C>T) mutation with a Hb Zurich-Langstrasse (HBB: c.151A>T) mutation in cis].
    Hemoglobin. 2022;46:249-252.
    PubMed     Abstract available
    
    
    
41. ZHANG L, Bao LJ, Hong ZD, Yan MX, et al
    Dysregulated Serum Cytokine Production in Pediatric Patients with beta-Thalassemia Major.
    Hemoglobin. 2022;46:191-196.
    PubMed     Abstract available
    
    
    May 2022
42. MANCO L, Santos R, Rocha C, Relvas L, et al
    Hb F Levels in beta-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the beta-Globin Gene Cluster.
    Hemoglobin. 2022;46:168-175.
    PubMed     Abstract available
    
    
    
43. REN ZM, Xing ZH, Chen SL, Fu XY, et al
    Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing.
    Hemoglobin. 2022;46:160-163.
    PubMed     Abstract available
    
    
    
44. KURUCU B, Fettah A, Capkinoglu E, Oner N, et al
    Dynamic Thiol-Disulfide Homeostasis in Children With beta-Thalassemia Trait.
    Hemoglobin. 2022;46:164-167.
    PubMed     Abstract available
    
    
    
45. KHAMPHIKHAM P, Sakkhachornphop S, Pongsatha S, Pornprasert S, et al
    Strong Positive Dichlorophenolindophenol Precipitation Suggests Hb Dhonburi (or Hb Neapolis) (HBB: c.380T>G) Inheritance in a Couple at Risk for Severe beta-Thalassemia.
    Hemoglobin. 2022;46:184-186.
    PubMed     Abstract available
    
    
    
46. PARSASEFAT M, Safarpour H, Nomiri S, Miri-Moghaddam E, et al
    Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through CA1 and LIN28B Genes: An In Vitro Study.
    Hemoglobin. 2022;46:153-159.
    PubMed     Abstract available
    
    
    
47. MORADI K, Aznab M, Azimi A, Biglari M, et al
    alpha-Thalassemia Mutations in Ilam Province, West Iran.
    Hemoglobin. 2022;46:147-152.
    PubMed     Abstract available
    
    
    March 2022
48. VARELAS C, Gavriilaki E, Sakellari I, Klonizakis F, et al
    Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Hemoglobin. 2022;46:143-145.
    PubMed     Abstract available
    
    
    
49. MANGANAS K, Delicou S, Xydaki A, Koskinas J, et al
    Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Hemoglobin. 2022;46:114-117.
    PubMed     Abstract available
    
    
    
50. ZARKADA E, Yfanti E, Teli A, Balassopoulou A, et al
    Rare Pathogenic beta(0)-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece.
    Hemoglobin. 2022;46:140-142.
    PubMed     Abstract available
    
    
    
51. SAHA D, Chowdhury PK, Panja A, Pal D, et al
    Effect of deletions in the alpha-globin gene on the phenotype severity of beta-thalassemia.
    Hemoglobin. 2022;46:118-123.
    PubMed     Abstract available
    
    
    
52. EFSTATHIOU A, Boutou E, Teli A, Drikos I, et al
    A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.
    Hemoglobin. 2022;46:132-136.
    PubMed     Abstract available
    
    
    
53. KITTIPOOM T, Tantiworawit A, Punnachet T, Hantrakun N, et al
    The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database.
    Hemoglobin. 2022;46:75-80.
    PubMed     Abstract available
    
    
    
54. JIANG F, Chen GL, Li J, Tang XW, et al
    beta-Thalassemia Intermedia Caused by the beta-Globin Gene 3' Untranslated Region: Another Case Report.
    Hemoglobin. 2022;46:137-139.
    PubMed     Abstract available
    
    
    
55. KARAKAYA T, Silan F, Ozdemir O
    A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.
    Hemoglobin. 2022;46:87-90.
    PubMed     Abstract available
    
    
    
56. ZAMAN BA, Ibrahim SA
    Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in beta-Thalassemia Major Patients.
    Hemoglobin. 2022;46:106-113.
    PubMed     Abstract available
    
    
    
57. BICILIOGLU Y, Bal A, Demir Yenigurbuz F, Ergonul E, et al
    Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.
    Hemoglobin. 2022;46:95-99.
    PubMed     Abstract available
    
    
    
58. BINDING A
    Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital.
    Hemoglobin. 2022;46:91-94.
    PubMed     Abstract available
    
    
    January 2022
59. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    PubMed     Abstract available
    
    
    
60. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    PubMed     Abstract available
    
    
    
61. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    PubMed     Abstract available
    
    
    
62. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    PubMed     Abstract available
    
    
    
63. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    PubMed     Abstract available
    
    
    
64. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    PubMed     Abstract available
    
    
    
65. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    PubMed     Abstract available
    
    
    
66. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.
    PubMed    
    
    
    
67. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    PubMed     Abstract available
    
    
    
68. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    PubMed     Abstract available
    
    
    
69. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    PubMed     Abstract available
    
    
    
70. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    PubMed     Abstract available
    
    
    
71. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    PubMed     Abstract available
    
    
    
72. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    PubMed     Abstract available
    
    
    
73. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    PubMed     Abstract available
    
    
    
74. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    PubMed     Abstract available
    
    
    
75. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    PubMed     Abstract available
    
    
    November 2021
76. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    PubMed     Abstract available
    
    
    
77. DEHURY S, Mohanty PK, Patel S, Meher S, et al
    Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with alpha-Thalassemia and beta-Globin Gene Cluster Haplotypes from Odisha, India.
    Hemoglobin. 2021;45:380-386.
    PubMed     Abstract available
    
    
    
78. CHAN NCN, Wong THY, Cheng KCK, Chan NPH, et al
    An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong.
    Hemoglobin. 2021;45:387-391.
    PubMed     Abstract available
    
    
    
79. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Hemoglobin. 2021;45:371-379.
    PubMed     Abstract available
    
    
    
80. FARRA C, Abdouni L, Souaid M, Awwad J, et al
    The Spectrum of beta-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
    Hemoglobin. 2021;45:365-370.
    PubMed     Abstract available
    
    
    
81. TSITSIKAS DA, Kamal M, Braimoh A, Benson S, et al
    Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
    Hemoglobin. 2021;45:355-357.
    PubMed     Abstract available
    
    
    
82. ALIYEVA G, Abdulalimov E, Asadov C, Mammadova T, et al
    First Report of beta-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T) Mutations.
    Hemoglobin. 2021;45:347-348.
    PubMed     Abstract available
    
    
    September 2021
83. HUANG LF, Yu LL, Nikuze L, Singh S, et al
    Spectrum of beta-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0-15 Years.
    Hemoglobin. 2021;45:318-321.
    PubMed     Abstract available
    
    
    
84. HAMALI HA
    Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
    Hemoglobin. 2021;45:287-295.
    PubMed     Abstract available
    
    
    
85. YADAV DD, Jamwal M, Singh N, Sharma R, et al
    Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing.
    Hemoglobin. 2021;45:338-340.
    PubMed     Abstract available
    
    
    
86. RUENGDIT C, Punyamung M, Khamphikham P, Pongpunyayuen P, et al
    Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia.
    Hemoglobin. 2021;45:309-313.
    PubMed     Abstract available
    
    
    
87. TRUTTMANN R, Schmidt A, Hartmann B, Rusch S, et al
    Description of Hb Evora (HBA2: c.106T>C) on an Unexpected Allele in a Swiss Family.
    Hemoglobin. 2021;45:314-317.
    PubMed     Abstract available
    
    
    
88. ZAHRA A, Ragab A, Al-Abboh H, Ismaiel A, et al
    Perforated Duodenal Ulcer Associated with Deferasirox in a Child with beta-Thalassemia Major.
    Hemoglobin. 2021;45:335-337.
    PubMed     Abstract available
    
    
    
89. CHEN HQ, Wu LS, Jiang F, Li DZ, et al
    Dominant beta-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
    Hemoglobin. 2021;45:329-331.
    PubMed     Abstract available
    
    
    
90. SEN A, Seenappa V, Chakrabarti P, Dolai TK, et al
    First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the beta-Globin Gene in the Indian Population.
    Hemoglobin. 2021;45:325-328.
    PubMed     Abstract available
    
    
    
91. DELICOU S, Aggeli K, Magganas K, Patsourakos D, et al
    Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
    Hemoglobin. 2021;45:303-308.
    PubMed     Abstract available
    
    
    
92. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Hemoglobin. 2021;45:275-286.
    PubMed     Abstract available
    
    
    
93. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable alpha Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.
    Hemoglobin. 2021;45:322-324.
    PubMed     Abstract available
    
    
    
94. TRIPATHY I, Panja A, Dolai TK, Mallick AK, et al
    Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali beta-Thalassemia Major Children.
    Hemoglobin. 2021;45:296-302.
    PubMed     Abstract available
    
    
    July 2021
95. ATROSHI SD, Al-Allawi NAS, Eissa AA
    Updated Molecular Spectrum of beta-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Hemoglobin. 2021;45:239-244.
    PubMed     Abstract available
    
    
    
96. PERERA S, Allen A, Rees DC, Premawardhena A, et al
    Pitfalls in the Diagnosis of beta-Thalassemia Intermedia.
    Hemoglobin. 2021;45:265-268.
    PubMed     Abstract available
    
    
    
97. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.
    Hemoglobin. 2021;45:256-258.
    PubMed     Abstract available
    
    
    
98. ETEMAD K, Mohseni P, Aghighi M, Bahadorimonfared A, et al
    Quality of Life and Related Factors in beta-Thalassemia Patients.
    Hemoglobin. 2021;45:245-249.
    PubMed     Abstract available
    
    
    
99. UCUCU S, Karabiyik T, Azik FM
    IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/beta(+)-Thalassemia Phenotype in an Hb S Trait Patient.
    Hemoglobin. 2021;45:225-227.
    PubMed     Abstract available
    
    
    
100. IDRIS IM, Yusuf AA, Gwarzo DH, Kurawa MS, et al
     High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
     Hemoglobin. 2021;45:228-233.
     PubMed     Abstract available
     
     
     
101. MARTIN G, Grimholt RM, Le D, Bechensteen AG, et al
     Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a beta-Thalassemia Major Phenotype.
     Hemoglobin. 2021;45:215-219.
     PubMed     Abstract available
     
     
     
102. RAFAT M, Allamehzadeh Z, Shekari M, Afsa M, et al
     The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the beta-Globin Promoter: Case Series Study.
     Hemoglobin. 2021;45:234-238.
     PubMed     Abstract available
     
     
     
103. JIANG F, Tang XW, Li J, Zhou JY, et al
     Hb Lepore-Hong Kong: First Report of a Novel delta/beta-Globin Gene Fusion in a Chinese Family.
     Hemoglobin. 2021;45:220-224.
     PubMed     Abstract available
     
     
     June 2021
104. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
     Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
     Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
     PubMed     Abstract available
     
     
     May 2021
105. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
     Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
     Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
     PubMed     Abstract available
     
     
     
106. BROWN BJ, Madu A, Sangeda RZ, Nkya S, et al
     Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
     Hemoglobin. 2021;45:163-170.
     PubMed     Abstract available
     
     
     
107. TSOLAKIDIS V, Vlachaki E, Papaioannou M, Pantelidou D, et al
     Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece.
     Hemoglobin. 2021;45:143-149.
     PubMed     Abstract available
     
     
     
108. MOORE JA, Pullon BM, Wang D, Brennan SO, et al
     Hb Tacoma: G>T or G>C, and Does It Matter?
     Hemoglobin. 2021;45:203-206.
     PubMed     Abstract available
     
     
     
109. SOOD R, Rastogi P, Bansal D, Das R, et al
     An Autopsy Case of beta-Thalassemia Major Illuminating the Pathological Spectrum of the Disease.
     Hemoglobin. 2021;45:180-185.
     PubMed     Abstract available
     
     
     
110. ATROSHI SD, Al-Allawi N, Chui DHK, Najmabadi H, et al
     A Novel beta(0)-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd.
     Hemoglobin. 2021;45:212-214.
     PubMed     Abstract available
     
     
     
111. SAENSUWANNA A, Penglong T, Srinoun K
     Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF4.
     Hemoglobin. 2021;45:197-202.
     PubMed     Abstract available
     
     
     
112. RUJEERAPAIBOON N, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
     Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients.
     Hemoglobin. 2021;45:175-179.
     PubMed     Abstract available
     
     
     
113. THEPPORNPITAK K, Trakarnsanga B, Lauhasurayotin S, Poparn H, et al
     A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
     Hemoglobin. 2021;45:171-174.
     PubMed     Abstract available
     
     
     
114. LUO LP, Ma L, Lin SB, Huang JG, et al
     Elevated Hb A2 is Not Always Indicative of beta-Thalassemia.
     Hemoglobin. 2021;45:186-190.
     PubMed     Abstract available
     
     
     
115. SAHA J, Panja A, Nayek K
     The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/beta-Thalassemia Children in a Tertiary Center of West Bengal, India.
     Hemoglobin. 2021;45:157-162.
     PubMed     Abstract available
     
     
     
116. TIAN Q, Lei YL, Xu LL, Li DZ, et al
     First Report of Nondeletional Hb H Disease Caused by an alpha2-Globin Gene Mutation: HBA2: c.184A>T.
     Hemoglobin. 2021;45:210-211.
     PubMed     Abstract available
     
     
     March 2021
117. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
     Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
     Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
     PubMed     Abstract available
     
     
     
118. OGU UO, Reyes Gil M, Tolu SS, Acharya SA, et al
     First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G).
     Hemoglobin. 2021;45:136-139.
     PubMed     Abstract available
     
     
     
119. YIN Z, Hao Y, Huang X, Chen X, et al
     A Novel Mutation at HBA1: c.349G>T Causing alpha-Thalassemia in a Chinese Family.
     Hemoglobin. 2021;45:94-96.
     PubMed     Abstract available
     
     
     
120. MARTINEZ VILLEGAS O, Mendoza-Melendez D, Trueba-Gomez R, Rosenfeld-Mann F, et al
     Analysis of a Novel Mexican Variant of the HBB Gene Associated with beta-Thalassemia Using Bioinformatic Tools.
     Hemoglobin. 2021;45:87-93.
     PubMed     Abstract available
     
     
     
121. INATI A, Al Alam C, El Ojaimi C, Hamad T, et al
     Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
     Hemoglobin. 2021;45:80-86.
     PubMed     Abstract available
     
     
     
122. PANICHCHOB P, Iamdeelert P, Wongsariya P, Wongsariya P, et al
     Molecular Spectrum of beta-Thalassemia Mutations in Central to Eastern Thailand.
     Hemoglobin. 2021;45:97-102.
     PubMed     Abstract available
     
     
     
123. SHARIFI F, Safizadeh H, Bahrampour A
     Development of the Quality of Life Questionnaire (SF-36) for Patients with beta-Thalassemia Major and beta-Thalassemia Intermedia Based on Extended Rasch Analysis.
     Hemoglobin. 2021;45:119-123.
     PubMed     Abstract available
     
     
     
124. ZARDKHONI SZ, Moghaddam AG, Rad F, Ghatee MA, et al
     Serum Zinc Level in beta-Thalassemia Major: A Retrospective Study in Southwest Iran.
     Hemoglobin. 2021;45:103-106.
     PubMed     Abstract available
     
     
     
125. ZHAO YL, Lin QF, He XW, Li YQ, et al
     Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.
     Hemoglobin. 2021;45:133-135.
     PubMed     Abstract available
     
     
     
126. SOLTANI D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, et al
     Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with beta-Thalassemia Major.
     Hemoglobin. 2021;45:107-111.
     PubMed     Abstract available
     
     
     
127. COLAH RB, Nadkarni AH, Gorakshakar AC, Sawant PM, et al
     The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades.
     Hemoglobin. 2021;45:112-118.
     PubMed     Abstract available
     
     
     
128. RUENGDIT C, Khamphikham P, Jinorose N, Pornprasert S, et al
     Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -(CR)) alpha(0)-Thalassemia in Two Unrelated Thai Families.
     Hemoglobin. 2021;45:75-79.
     PubMed     Abstract available
     
     
     
129. WANG RY, Jiang F, Xu LL, Li DZ, et al
     Mild alpha-Thalassemia Caused by a Mosaic alpha-Globin Gene Mutation.
     Hemoglobin. 2021;45:140-141.
     PubMed     Abstract available
     
     
     January 2021
130. MEHER S, Mohanty PK, Patel S, Das K, et al
     Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
     Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
     PubMed     Abstract available
     
     
     
131. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
     beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
     Hemoglobin. 2021;45:1-4.
     PubMed     Abstract available
     
     
     
132. CHEN X, Lin Z, Hu J, Chen S, et al
     Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.
     Hemoglobin. 2021;45:52-55.
     PubMed     Abstract available
     
     
     
133. LIU L, Sun Y, Chen S, Yu C, et al
     Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.
     Hemoglobin. 2021;45:49-51.
     PubMed     Abstract available
     
     
     
134. AL-ZUHAIRY SH, Darweesh MA, Othman MA
     Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with beta-Thalassemia Major.
     Hemoglobin. 2021;45:69-73.
     PubMed     Abstract available
     
     
     
135. BALLAS SK, Riddick-Burden G, Congdon-Martin E
     Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs.
     Hemoglobin. 2021;45:62-65.
     PubMed     Abstract available
     
     
     
136. TARIQ A, Khurshid S, Sajjad M
     Evaluation of the High Resolution Melting Approach for Detection of beta-Thalassemia Gene Mutations.
     Hemoglobin. 2021;45:20-24.
     PubMed     Abstract available
     
     
     
137. LIN QY, Chen DY, Kong S, Liu WQ, et al
     A Rare Case of Hb H Disease and Systemic Lupus Erythematosus.
     Hemoglobin. 2021;45:66-68.
     PubMed     Abstract available
     
     
     
138. WANG WJ, Ding ZX, Zhang HM, Tao TT, et al
     Identification of a Novel beta-Thalassemia Mutation at Codon 130 (+T) (HBB: c.391insT) in Han Chinese.
     Hemoglobin. 2021;45:46-48.
     PubMed     Abstract available
     
     
     
139. GOLLAMUDI J, Sarvepalli S, Vadaparti Binf A, Alin T, et al
     Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.
     Hemoglobin. 2021;45:56-59.
     PubMed     Abstract available
     
     
     
140. SIGAL IR, Ciunci CA
     Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
     Hemoglobin. 2021;45:60-61.
     PubMed     Abstract available
     
     
     
141. DOULGERAKI A, Fragodimitri C, Athanasopoulou H, Drakaki K, et al
     Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
     Hemoglobin. 2021;45:30-36.
     PubMed     Abstract available
     
     
     
142. AYDOGDU S, Toret E, Aksoy BA, Aydin MF, et al
     Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types.
     Hemoglobin. 2021;45:25-29.
     PubMed     Abstract available
     
     
     
143. ANGASTINIOTIS M, Petrou M, Loukopoulos D, Modell B, et al
     The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.
     Hemoglobin. 2021;45:5-12.
     PubMed     Abstract available
     
     
     
144. LIEDERMAN Z, Quartey NK, Ward R, Papadakos J, et al
     Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care.
     Hemoglobin. 2021;45:13-19.
     PubMed     Abstract available
     
     
     November 2020
145. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
     High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
     Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
     PubMed     Abstract available
     
     
     July 2020
146. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
     Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
     Hemoglobin. 2020;44:284-289.
     PubMed     Abstract available
     
     
     March 2020
147. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
     Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
     Hemoglobin. 2020;44:122-127.
     PubMed     Abstract available
     
     
     
148. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
     Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
     Hemoglobin. 2020;44:78-81.
     PubMed     Abstract available
     
     
     
149. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
     Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
     Hemoglobin. 2020;44:139-142.
     PubMed     Abstract available
     
     
     
150. HORRI-NACEUR A, Timson DJ
     In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
     Hemoglobin. 2020;44:89-103.
     PubMed     Abstract available
     
     
     
151. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
     Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
     Hemoglobin. 2020;44:128-130.
     PubMed     Abstract available
     
     
     
152. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
     Hb H Disease Diagnosed During Adolescent Pregnancy.
     Hemoglobin. 2020;44:137-138.
     PubMed     Abstract available
     
     
     
153. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
     Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
     Hemoglobin. 2020;44:109-112.
     PubMed     Abstract available
     
     
     
154. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
     Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
     Hemoglobin. 2020;44:134-136.
     PubMed     Abstract available
     
     
     
155. JIANG F, Xu LL, Chen GL, Zhou JY, et al
     Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
     Hemoglobin. 2020;44:86-88.
     PubMed     Abstract available
     
     
     
156. MANCO L, Bento C, Relvas L, Cunha E, et al
     Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
     Hemoglobin. 2020;44:113-117.
     PubMed     Abstract available
     
     
     
157. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
     Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
     Hemoglobin. 2020;44:104-108.
     PubMed     Abstract available
     
     
     
158. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
     Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
     Hemoglobin. 2020;44:71-77.
     PubMed     Abstract available
     
     
     
159. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
     A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
     Hemoglobin. 2020;44:131-133.
     PubMed     Abstract available
     
     
     January 2020
160. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
     Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
     Hemoglobin. 2020;44:31-36.
     PubMed     Abstract available
     
     
     
161. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
     Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
     Hemoglobin. 2020;44:1-9.
     PubMed     Abstract available
     
     
     
162. MASHON RS, Das R, Dhawan R, Kakkar N, et al
     Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
     Hemoglobin. 2020;44:64-66.
     PubMed     Abstract available
     
     
     
163. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
     Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
     Hemoglobin. 2020;44:47-50.
     PubMed     Abstract available
     
     
     
164. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
     Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
     Hemoglobin. 2020;44:37-41.
     PubMed     Abstract available
     
     
     
165. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
     alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
     Hemoglobin. 2020;44:20-26.
     PubMed     Abstract available
     
     
     
166. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
     Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
     Hemoglobin. 2020;44:17-19.
     PubMed     Abstract available
     
     
     
167. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
     An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
     Hemoglobin. 2020;44:61-63.
     PubMed     Abstract available
     
     
     
168. LUO H, Zou Y, Liu Y
     A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
     Hemoglobin. 2020;44:55-57.
     PubMed     Abstract available
     
     
     
169. CHEN X, Luo S, Huang J, Yuan D, et al
     Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
     Hemoglobin. 2020;44:51-54.
     PubMed     Abstract available
     
     
     
170. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
     A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
     Hemoglobin. 2020;44:58-60.
     PubMed     Abstract available
     
     
     
171. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
     Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
     Hemoglobin. 2020;44:42-46.
     PubMed     Abstract available
     
     
     
172. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
     Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
     Hemoglobin. 2020;44:27-30.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: